We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Clinical Development Program Utilizing Xenomics' DNA-Based Diagnostic Technology is Ranked Best in Europe

European Consortium led By Xenomics' collaborative venture with leading European research center prepares for euro 2 million funding of tuberculosis clinical program.
News

Study Says Stem Cell 'Fusion' Occurs In Tumors

The findings point to the integral role of bone marrow-derived cells in not only regeneration of damaged tissue, but also disease progression.
News

RCP Diagnostics Licenses Its Protein Marker to Biomarker Technologies

Biomarker will use the RCP marker only for the diagnosis of breast cancer.
News

Cerep Grants BioPrint® Access to AstraZeneca

AstraZeneca will have non-exclusive access to physicochemical, pharmacological and clinical data on BioPrint® compounds.
News

NIEHS Researchers Link Gene Variation to Coronary Heart Disease

The research builds on a body of evidence suggesting the importance of Caucasians that carries the gene variation.
News

Nanophase Cosponsors Fifth Annual Nanobusiness Alliance Conference

Joseph Cross, Nanophase’s president and CEO, will address the conference.
News

Illinois Grant Supports Stem Cell Research at UIC

Of the total, $2 million will be used to establish a center for the development of stem cell therapies for human diseases.
News

Open Biosystems Gains Momentum in European RNAi Market

Open Biosystems' Open Access RNAi Program provides CIC bioGUNE with shRNAmir technology.
News

Celera and Collaborators Discover Genetic Markers Associated with Heart Attacks

The key finding of the study was that variants of the VAMP8 and HNRPUL1 genes were associated with early-onset MI.
News

Nonlinear Enter Co-Marketing Agreement with Agilent

The agreement is centred on synergies between the Agilent 2100 bioanalyzer 'lab-on-a-chip' platform and Nonlinear’s TL120 DM software.
Advertisement